Diabetes in Urban African-Americans. VI. Utility of Fasting or Random Glucose in Identifying Poor Glycemic Control
- 1 April 1998
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 21 (4) , 501-505
- https://doi.org/10.2337/diacare.21.4.501
Abstract
OBJECTIVE African-Americans have an increased prevalence of both diabetes and diabetes complications, creating an imperative for improved metabolic control. Because American Diabetes Association guidelines recommend that action be taken when HbA1c is >8.0', but access to rapid-turnaround HbA1c assays remains limited, we tested the utility of fasting and random plasma glucose cutoffs as indicators of HbA1c >8.0%. RESEARCH DESIGN AND METHODS Using receiver operating characteristics (ROC) analysis, we evaluated the sensitivity, specificity, and predictive value of fasting and random plasma glucose measurements in identifying an HbA1c >8.0% (fasting n = 974, random n = 552). The population studied was predominantly African-American, middle-aged, and noninsulin-dependent. RESULTS Fasting plasma glucose was a significant indicator of HbA1c >8.0%, both in the whole group and in subgroups for diet, sulfonylureas, and insulin; the corresponding areas under the ROC curve were 0.87, 0.90, 0.87, and 0.84, respectively (all P < 0.0001). A fasting plasma glucose cutoff of >9.2 mmol/1 (165 mg/dl) provided a sensitivity of 80% and a specificity of 83% for the whole group and a 77% positive predictive value. Random plasma glucose was also a good indicator of HbA1c >8.0%, both in the whole group and in subgroups for diet, sulfonylureas, and insulin; the corresponding areas under the ROC curve were 0.85, 0.91, 0.85, and 0.77, respectively (all P < 0.0001). A cutoff >9.8 mmol/1 (177 mg/dl) provided a sensitivity of 78% and a specificity of 77% for the whole group and a 78% positive predictive value. Overall, a plasma glucose >11.1 mmol/1 (200 mg/dl) identified an HbA1c >8.0% with a predictive value of ∼90% if done while fasting and a predictive value of ∼80–85% if random. The utility of both fasting and random plasma glucose cutoffs was subsequently confirmed in a prospective study of another 2,309 and 1,396 patients, respectively. CONCLUSIONS Although glucose levels cannot replace HbA1c determinations, measurement of fasting or random plasma glucose may be used during a clinic visit to identify poorly controlled type 2 patients with reasonable certainty and allow timely patient education and therapeutic intervention.This publication has 11 references indexed in Scilit:
- Diabetes in urban african americans. III. Management of type II diabetes in a municipal hospital settingThe American Journal of Medicine, 1996
- The Feasibility of Intensive Insulin Management in Non-Insulin-dependent Diabetes Mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDMAnnals of Internal Medicine, 1996
- Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trialDiabetes Care, 1995
- Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDMDiabetes Care, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- NIDDM and its metabolic control predict coronary heart disease in elderly subjectsDiabetes, 1994
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982
- Monitoring Metabolic Control in Diabetic Outpatients with Glycosylated HemoglobinAnnals of Internal Medicine, 1980